Skip to main content
RAMM Pharma Corp. logo

RAMM Pharma Corp. — Investor Relations & Filings

Ticker · RAMM CSE Manufacturing
Filings indexed 134 across all filing types
Latest filing 2024-07-05 Regulatory Filings
Country CA Canada
Listing CSE RAMM

About RAMM Pharma Corp.

https://www.wearerammpharma.com/

RAMM Pharma Corp. is a pharmaceutical and medical product company specializing in cannabinoid pharmacology and product formulation. The company develops and commercializes plant-derived cannabinoid pharmaceuticals, cosmetics, and pet care products. Key operations include Medic Plast, which produces medically registered prescription CBD solutions (Epifractán and Xalex 10) approved by the Ministry of Public Health of Uruguay. RAMM also addresses the pet market through NettaLife (NettaVet CBD drops and NettaPet food) and the European cosmetic and nutraceutical sectors via Canapar, which operates a high-tech cannabis extraction facility in Sicily. The company utilizes cultivation facilities in Uruguay and focuses on expanding distribution agreements across Latin America.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date (amended) - English.pdf
Regulatory Filings
2024-07-05 English
Statement of executive compensation (form 51-102F6V) - English.pdf
Regulatory Filings
2024-06-04 English
News release - English.pdf
Regulatory Filings
2024-03-28 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2024-03-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-03-28 English
Interim MD&A - English.pdf
Regulatory Filings
2024-03-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.